Freeflow Ventures
Freeflow Ventures is an early-stage deep tech venture capital firm investing pre-seed through Series B in science-driven companies from Caltech, UC Berkeley, and UCSF, focused on human and planetary health.
- Company typePrivate
- Founded2019
- HeadquartersPasadena, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Freeflow Ventures does
Freeflow Ventures is a private, early-stage venture capital firm founded in 2019 that invests pre-seed through Series B in science-driven deep technology companies addressing human and planetary health challenges. The firm operates an upstream, relationship-driven sourcing model anchored at three premier research institutions — Caltech (since founding), UC Berkeley (since 2023), and UCSF (since 2025-2026) — and engages founders for roughly ten months prior to first institutional investment. Freeflow supports portfolio companies with non-science operating help, including fundraising, marketing, hiring, and strategy, complementing IP-, AI-, and ML-driven technological differentiation in founders.
The firm manages three investment vehicles totaling $90M AUM — Fund One ($25M, 2019), Fund Two ($35M, 2024), and an Opportunity Fund ($15M, 2024) — augmented by SPVs for breakout companies. It has invested in more than 30 companies to date and counts more than 100 distinct co-investors from venture and corporate capital. Co-investor network spans corporate strategics (Nvidia, Lilly, Equinor, Philips, Johnson & Johnson) and venture peers (SOSV, LKS Fund, Lifespan Vision Ventures, YK Bioventures, Berkeley Frontier Fund, Pillar). Portfolio spans therapeutics (Iambic, Sift Biosciences, TippingPoint Biosciences, Vivere Oncotherapies, Holoclara, Catena Bio), diagnostics (StrokeDx), and planetary-health technologies (Captura, Hydrosat, Membrion, Flion Energy).
Freeflow's revenue model follows standard venture fund economics: management fees on committed capital plus carried interest on portfolio realizations. The leadership team — Founder & Managing Partner David Fleck, Managing Partner Kevin Barrett (former CEO of Altegra Health, sold to Change Healthcare for over $900M), and Operating Partner Steve Roy — sits atop a scientific advisory board that includes Nobel Laureates Frances Arnold, David Baltimore, and Bob Grubbs. Fred Wilson (Co-founder, Union Square Ventures) is identified as a Limited Partner, indicating institutional LP backing. The firm reports 1-10 employees and lists Pasadena and Berkeley, California as operating geographies.
Freeflow Ventures firmographics
Firmographics- Name
- Freeflow Ventures
- Legal name
- Freeflow Ventures
- Website
- https://freeflow.io
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Freeflow Ventures is an early-stage deep tech venture capital firm investing pre-seed through Series B in science-driven companies from Caltech, UC Berkeley, and UCSF, focused on human and planetary health.
- Ownership category
- akta.pro rank
Freeflow Ventures industry classification
Industry- Product category
- Venture Capital
- NAICS
- Other Investment Pools and Funds (5259), Other Financial Vehicles (525990)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)
- akta.pro secondary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
Keywords
Where Freeflow Ventures is headquartered
LocationHeadquarters
- HQ city
- Pasadena
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Freeflow Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Venture Capital Returns (Carried Interest): Freeflow generates returns through carried interest on successful portfolio company exits, as is standard for venture capital firms.
- Management Fees: VC firms typically charge management fees on committed capital from LPs, typically 2% of AUM annually.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Freeflow Ventures product offering
Product offeringCore offering
Freeflow Ventures is an early-stage venture capital firm that makes pre-seed, seed, Series A, and Series B equity investments in science-driven deep tech companies addressing human and planetary health challenges. The firm primarily sources deals from the Caltech, UC Berkeley, and UCSF research ecosystems and provides portfolio companies with non-science value-add services including fundraising, marketing, hiring, and strategic support. It operates three funds totaling $90M in assets under management and has invested in over 30 companies since founding in 2019.
Product overview
Freeflow Ventures is an early-stage venture capital firm that does not offer commercial products or services. The firm operates investment funds (Fund One $25M, Fund Two $35M, and Opportunity Fund $15M, totaling $90M AUM) and provides support services to portfolio companies including fundraising assistance, marketing, hiring, and strategy. The company focuses on investing in science-driven deep tech companies addressing human and planetary health challenges, primarily sourcing from Caltech, UC Berkeley, and UCSF ecosystems.
Differentiator
Problem solved
Functional benefit
Products and services
- Fund One Freeflow's inaugural $25M early-stage venture capital fund launched at Caltech in 2019, deploying capital into science-driven deep tech companies addressing human and planetary health challenges. Open to limited partner commitments.
- Fund Two Freeflow's second $35M venture capital fund closed in June 2024, expanding investments into Berkeley and UCSF ecosystems alongside continued Caltech activity. Open to limited partner commitments.
- Opportunity Fund Freeflow's first Opportunity Fund at $15M, closed in early 2024, focused on follow-on investments into breakout portfolio companies. Open to limited partner commitments.
Companies that use Freeflow Ventures
Customer profileSegments2 records
Ideal customer profiles2 records
Freeflow Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Freeflow Ventures partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- CaltechcorePrimary ecosystem for deal sourcing; Freeflow launched at Caltech in 2019, has made over 30 investments in Caltech-affiliated companies. Scientific advisory board includes Caltech faculty including Nobel laureates Frances Arnold, David Baltimore, and Bob Grubbs
- UC BerkeleycoreExpanded ecosystem in 2023 to Berkeley; investment into Catena Bio as first Berkeley ecosystem investment. Scientific advisor Dave Schaffer leads Berkeley's QB3, Bakar Labs, and Bakar Fellows Program
- UCSFcoreExpanded into UCSF ecosystem in 2026; first investment was TippingPoint Biosciences, a UCSF-born therapeutics company. UCSF received $824M in NIH funding in 2025 (largest public recipient)
- Lawrence Berkeley National LaboratorycoreCollaboration for portfolio companies including Erg Bio (spun out of Joint BioEnergy Institute) and technology partnerships
- Bakar LabscoreBerkeley incubator supporting biotech startups; Catena Bio is a member of Bakar BioEngenuity Hub
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Freeflow Ventures competitors and assessment
Company assessmentDirect peers
- Lux Capital: Lux Capital is one of the most prominent deep tech / science-focused venture firms, investing at the intersection of frontier science, engineering, and computing. Like Freeflow, Lux differentiates through deep relationships with academic research communities and Nobel-adjacent founders, making it the closest direct comp in model and category.
- DCVC (Data Collective): DCVC invests early in deep tech companies applying computational and engineering breakthroughs in biology, energy, and advanced materials. Its science-led thesis, early-stage focus, and concentration in California research ecosystems make it a tight peer to Freeflow.
- Playground Global: Playground Global is an early-stage venture firm investing in frontier tech — robotics, biotech, energy, and computing infrastructure. It shares Freeflow's deep-tech orientation, early-stage entry, and willingness to back hard-tech founders out of world-class research labs.
- ARCH Venture Partners: ARCH is a science-focused venture firm co-founding and incubating companies from university and national lab research. Like Freeflow, it sources heavily from elite research institutions (including Caltech) and concentrates on human health and energy, making it a comparable model at larger scale.
- Atlas Venture: Atlas Venture is an early-stage biotech-focused venture firm building companies from inception. It shares Freeflow's pre-seed/seed orientation, focus on human health, and willingness to co-found therapeutics ventures out of academic labs.
- Section32: Section32 is a science-and-health-focused venture fund investing early in companies emerging from top research institutions. Its California footprint, science-led sourcing, and co-investor overlap with Freeflow make it a meaningful peer.
- Material Change Institute (Material Impact): Material Impact is an early-stage deep tech firm focused on hard-tech and science-driven companies in human health, climate, and advanced materials. Its pre-seed/seed posture and academic sourcing align closely with Freeflow's model.
Broad incumbents
- Khosla Ventures: Khosla Ventures is a broad incumbent covering deep tech, biotech, climate, and frontier science across stages. It overlaps with Freeflow on early-stage science-driven deals in therapeutics and climate, but at much larger fund scale and broader sector mandate.
- SOSV: SOSV is a global multi-stage VC operating accelerator-style programs in deep tech and biotech. It appears as a Freeflow co-investor (TippingPoint Biosciences) and competes for similar academic spinout deal flow at larger scale.
- Y Combinator: Y Combinator is the dominant pre-seed/seed accelerator and increasingly active in deep tech and biotech. While it serves software-first founders at far larger scale, it competes for the earliest-stage science spinouts Freeflow targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Freeflow Ventures social profiles
Digital presenceFreeflow Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Freeflow Ventures leadership team
Management profileNumber of profiles
Profiles3 records
Freeflow Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Freeflow Ventures M&A and investment
M&A and investmentM&A
Investments32 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Freeflow Ventures
What does Freeflow Ventures do?
Freeflow Ventures is an early-stage venture capital firm that makes pre-seed, seed, Series A, and Series B equity investments in science-driven deep tech companies addressing human and planetary health challenges. The firm primarily sources deals from the Caltech, UC Berkeley, and UCSF research ecosystems and provides portfolio companies with non-science value-add services including fundraising, marketing, hiring, and strategic support. It operates three funds totaling $90M in assets under management and has invested in over 30 companies since founding in 2019.
Is Freeflow Ventures a public or private company?
Freeflow Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Freeflow Ventures founded?
Freeflow Ventures was founded in 2019. It employs 1 to 10 people.
Where is Freeflow Ventures based?
Freeflow Ventures is headquartered in Pasadena, United States, in the North America region.
How does Freeflow Ventures make money?
Two revenue lines are on record. Venture Capital Returns (Carried Interest) is the primary driver. The others are management Fees.
Who are Freeflow Ventures's main competitors?
Direct peers on record are Lux Capital, DCVC (Data Collective), Playground Global, ARCH Venture Partners, Atlas Venture, Section32 and Material Change Institute (Material Impact). Broad incumbents are Khosla Ventures, SOSV and Y Combinator.
Does Freeflow Ventures have an API?
No public API is recorded for Freeflow Ventures.
What industry is Freeflow Ventures in?
Freeflow Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed), with a secondary code of FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 5259 and its SIC code is 6282.